Carregant...
Diabetes Drugs and Cardiovascular Safety
Diabetes is a well-known risk factor of cardiovascular morbidity and mortality, and the beneficial effect of improved glycemic control on cardiovascular complications has been well established. However, the rosiglitazone experience aroused awareness of potential cardiovascular risk associated with d...
Guardat en:
| Publicat a: | Endocrinol Metab (Seoul) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Endocrine Society
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923407/ https://ncbi.nlm.nih.gov/pubmed/27302713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2016.31.2.239 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|